Dalian BIO-CHEM Company Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,186	1,173	668.24	539.52	417.96	293.88
Trading Asset Securities	57.87	57.87	53.45	60.01	-	0.63
Cash & Short-Term Investments	1,244	1,231	721.7	599.54	417.96	294.51
Cash Growth	47.20%	70.52%	20.38%	43.44%	41.92%	-14.24%
Accounts Receivable	295.38	257.38	419.13	168.24	176.6	192.87
Other Receivables	19.58	19.73	132.45	222.09	224.56	1.09
Receivables	314.96	277.11	551.58	390.32	401.16	193.97
Inventory	1,050	1,056	925.76	206.94	181.04	186.73
Other Current Assets	137.42	73.44	390.85	70.64	50.32	52.56
Total Current Assets	2,746	2,637	2,590	1,267	1,050	727.77
Property, Plant & Equipment	675.88	689.67	696.43	619.51	630.4	825.83
Long-Term Investments	147.4	150.07	-	7.02	13.89	-
Goodwill	230.53	230.53	230.53	-	-	-
Other Intangible Assets	120.57	124.14	137.21	42.17	43.18	92.16
Long-Term Deferred Tax Assets	26.35	24.5	31.52	-	11.2	17.82
Long-Term Deferred Charges	27.42	28.82	25.74	-	-	0.55
Other Long-Term Assets	15.03	10.09	8.42	5.58	5.24	6.59
Total Assets	3,989	3,895	3,720	1,942	1,754	1,671
Accounts Payable	81.55	88.38	117.72	62.64	66.77	142.02
Accrued Expenses	17.07	36.64	30.62	16.09	17.86	14.26
Short-Term Debt	305.94	255.96	423.94	150.01	129.11	338.5
Current Portion of Long-Term Debt	-	273.09	29	-	-	-
Current Portion of Leases	281.74	10.72	6.49	0.4	-	-
Current Income Taxes Payable	30.94	27.41	45.86	13.93	-	0.16
Current Unearned Revenue	174.57	149.69	388.85	2.35	2.15	4.37
Other Current Liabilities	69.09	77.22	110.98	24.38	24.96	37.56
Total Current Liabilities	960.9	919.1	1,153	269.8	240.86	536.89
Long-Term Debt	830.59	783.31	86	-	-	-
Long-Term Leases	23.71	20.83	22.6	0.38	-	-
Long-Term Unearned Revenue	79.03	79.52	8.06	9.34	10.63	37.32
Long-Term Deferred Tax Liabilities	38.97	40.57	53.38	25.46	41.63	36.85
Other Long-Term Liabilities	2.78	12.76	6.49	-	-	10
Total Liabilities	1,936	1,856	1,330	304.99	293.12	621.07
Common Stock	706.22	706.22	504.45	360.32	258.95	261.35
Additional Paid-In Capital	141.77	141.7	97.03	78.96	129.71	139.68
Retained Earnings	970.83	950.41	1,245	1,214	1,190	787.04
Treasury Stock	-400.02	-400.02	-	-10.53	-117.72	-138.56
Comprehensive Income & Other	-8.76	-10.34	-11.58	-5.67	0.66	0.15
Total Common Equity	1,410	1,388	1,835	1,637	1,461	1,050
Minority Interest	643.42	650.68	554.78	-	-	-
Shareholders' Equity	2,053	2,039	2,390	1,637	1,461	1,050
Total Liabilities & Equity	3,989	3,895	3,720	1,942	1,754	1,671
Total Debt	1,442	1,344	568.03	150.79	129.11	338.5
Net Cash (Debt)	-197.62	-113.25	153.66	448.74	288.85	-44
Net Cash Growth	-	-	-65.76%	55.36%	-	-
Net Cash Per Share	-0.29	-0.16	0.22	0.64	0.42	-0.06
Filing Date Shares Outstanding	660.95	691.63	706.22	701.37	696.35	701.64
Total Common Shares Outstanding	660.95	691.63	706.22	701.37	696.35	701.64
Working Capital	1,785	1,718	1,436	997.63	809.62	190.88
Book Value Per Share	2.13	2.01	2.60	2.33	2.10	1.50
Tangible Book Value	1,059	1,033	1,467	1,595	1,418	957.5
Tangible Book Value Per Share	1.60	1.49	2.08	2.27	2.04	1.36
Buildings	-	356.02	356	352.23	329.53	413.34
Machinery	-	750.06	661.21	569.13	547.95	575.64
Construction In Progress	-	2.12	25.39	1.21	0.22	88.14